Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-44.25%Return on Equity
VS
Market
Sector
Industry
History
$ 4.95Close
$ 2.73 - $ 8.07 52-Week Range
Ticker Information
Ticker
VYGRCompany Name
VOYAGER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVOYAGER THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VYGR - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 243.94M | $ -107.93M | -44.25% |
| 3/31/2025 | $ 272.7M | $ -84.69M | -31.06% |
| 12/31/2024 | $ 299.76M | $ -65M | -21.68% |
| 9/30/2024 | $ 330.31M | $ 25.88M | 7.84% |
| 6/30/2024 | $ 335.42M | $ 9.02M | 2.69% |
| 3/31/2024 | $ 340.89M | $ -3.04M | -0.89% |
| 12/31/2023 | $ 236.32M | $ 132.33M | 56% |
| 9/30/2023 | $ 176.22M | $ 52.31M | 29.68% |
| 6/30/2023 | $ 199.03M | $ 95.83M | 48.15% |
| 3/31/2023 | $ 216.96M | $ 98.95M | 45.61% |
Key Performance Insights, Last 5 Years
- VOYAGER THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at 24.12%.
- Over the past 5 years, VOYAGER THERAPEUTICS INC's average ROE has been -14.45%.
- The median ROE for VOYAGER THERAPEUTICS INC during this period was 0.9%
- VOYAGER THERAPEUTICS INC reached its highest ROE over the past 5 years at 56%.
- The lowest ROE recorded by VOYAGER THERAPEUTICS INC in the same timeframe -106.19%
VOYAGER THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for VOYAGER THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ 40.09M ] / Equity [ $ 166.24M ]
(=) ROE [ 24.12% ] VYGR - Return on Equity, Last 5 years
-106.19%
Minimum
Sep 30, 2021
56%
Maximum
Dec 31, 2023
-14.45%
Average
0.9%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |